AnalystBook Research · Company Intelligence

GENMAB A/S

GMABNasdaq

Built from GENMAB A/S's own SEC filings · updates as new filings land · every figure links to its source

or browse all covered companies

← Research Library

The read at a glance

Computed from the FY2019 annual filing. Full history and the components behind each score are in the app.

  • Distress risk · Altman Z-Score 20.73 — safe zoneOK
  • Earnings-manipulation signal · Beneish M -1.50 — flag raised, worth a closer lookWatch

Latest filings

  • 6-K · Company announcement (foreign filer)2026-06-29
  • 6-K · Company announcement (foreign filer)2026-06-17
  • 6-K · Company announcement (foreign filer)2026-06-16
  • 6-K · Company announcement (foreign filer)2026-06-15
  • 6-K · Company announcement (foreign filer)2026-06-15
In the full recordFree for 14 days
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, every figure source-linked🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask anything about GENMAB A/S, every answer cited🔒
  • The Intelligence Brief — added when GENMAB A/S's brief passes our SEC-figure check🔒

Every figure links to the filing it came from, and analysis whose figures don't match SEC data is rejected before publication.

See the full GMAB record — start free

14-day free trial, no credit card. For research purposes only; not investment advice.